The strategic challenges of the French Healthtech sector - health, innovation, sovereignty - are undeniably its best assets for growth. How did this sector thwart the predictions during the Covid crisis and how did it find its financing?
French Healthtech raised more venture capital funds in the first half of 2020 than in 2019: showing agility in its search for funding[1]
Despite the absence of IPOs on Euronext in this sector for the past year, stock markets have not weakened...
October 13, 2020
6 min read
